—
Source: Fox News
Summary
A study by the University of Liverpool found that people with diabetes who took metformin, a prescription drug for type 2 diabetes, were 37% less likely to develop intermediate age-related macular degeneration (AMD) over five years compared to those not taking it. The study used eye pictures from 2,000 people and adjusted for factors such as age, sex, and diabetes duration.
Our Reading
The advice sounds familiar.
Metformin, a common medication for diabetes, may have a secondary benefit in slowing down age-related vision loss. Researchers at the University of Liverpool found that patients taking metformin were less likely to develop intermediate AMD over a five-year period. The study used eye pictures from 2,000 people and adjusted for various factors.
While the results are promising, the study was observational and did not prove metformin was the direct cause of the improvement. Additionally, the study only focused on people with diabetes and did not explore the effects on those without the condition.
Metformin’s potential benefits may be due to its anti-inflammatory and anti-aging properties, which could help protect the retina.
This guidance has been heard before, and it’s unclear whether the drug would have the same effect on people without diabetes.
—
Author: Evan Null
